Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01050127 · ClinicalTrials.gov registry record · Phase 1

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

A Phase 1 study of Healthy, sponsored by Abbott.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target
1
Study location

NCT01050127 is a Phase 1 study of Healthy that has completed, run by Abbott. The registered enrollment target is 36 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01050127, a Phase 1 study of Healthy, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The objectives of this study are to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of multiple doses of ABT-436 in healthy adults.

Conditions Studied

Healthy

Interventions

  • DRUG Placebo
  • DRUG ABT-436

Study Locations (1)

Illinois

  • Site Reference ID/Investigator# 24849 - Waukegan

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-12
Phase Phase 1

Sponsor

Abbott

181 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01050127

The ClinicalTrials.gov registry entry for NCT01050127 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01050127 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01050127 about?

NCT01050127 is a clinical study titled "A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults". The objectives of this study are to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of multiple doses of ABT-436 in healthy adults.

What is the current status of trial NCT01050127?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2009-12.

What conditions does trial NCT01050127 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01050127?

The interventions under investigation include: Placebo (DRUG), ABT-436 (DRUG).

Who is sponsoring clinical trial NCT01050127?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01050127 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.